APP and Alzheimer disease: Future studies aim to raise awareness of iron overload and aid in the development of mRNA-based medications to treat AD by elucidating the upstream and downstream roles of iron in AD pathogenesis, better understanding iron dysregulation, and uncovering the role of APP mRNA as a post-transcriptional regulator of amyloid protein synthesis.